Tilray | TRLY - Market Capitalization

Stock Price
9.23
Daily Change
-0.23 -2.43%
Monthly
-3.75%
Yearly
1,237.68%
Q2 Forecast
9.04

Tilray reported $7.16B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 1B 55.93M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 29.18B 9.2B Apr/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zealand Pharma A/S 33.35B 0 Apr/2026